Clinical Study of Tirellizumab Combined with Bevacizumab in the Treatment of Unresectable Advanced Liver Cancer

Clinical Study of Tirellizumab Combined with Bevacizumab in the Treatment of Unresectable Advanced Liver Cancer

YE Tianyun, ZHANG Qihong, XU Yunpeng

PDF(967 KB)

PDF(967 KB)

Chinese And Foreign Medical Research ›› 2023, Vol. 21 ›› Issue (29) : 41-45. DOI: 10.14033/j.cnki.cfmr.2023.29.011

Clinical practice

Clinical Study of Tirellizumab Combined with Bevacizumab in the Treatment of Unresectable Advanced Liver Cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 21(29): 41-45 https://doi.org/10.14033/j.cnki.cfmr.2023.29.011

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(967 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉